Now in clinic, Neomorph heads into AACR with $100M series B: Venture Report

As Neomorph heads into a set of presentations at AACR on a lead program that entered the clinic in February, the San Diego-based biotech announced its first venture round in more than five years.

Neomorph Inc. said Monday it had closed a $100 million series B round, with founding investor Deerfield Management joined by Regeneron Ventures, Longwood Fund, Alexandria Venture Investments and Binney Street Capital of the Dana-Farber Cancer Institute, among other undisclosed investors...